REFERENCES
1. Cao F, Guo N, Yuan Z. Reports from the 2021 Great Wall International
Congress of Cardiology in China. Eur Heart J 2021:ehab852.
2. Anker SD, Butler J, Khan MS, et al. Conducting clinical trials in
heart failure during (and after) the COVID-19 pandemic: an Expert
Consensus Position Paper from the Heart Failure Association (HFA) of the
European Society of Cardiology (ESC). Eur Heart J 2020;41:2109-17.
3. Bakris G, Ali W, Parati G. ACC/AHA Versus ESC/ESH on Hypertension
Guidelines: JACC Guideline Comparison. J Am Coll Cardiol
2019;73:3018-26.
4. Han Y, Zeng H, Jiang H, et al. CSC Expert Consensus on Principles of
Clinical Management of Patients With Severe Emergent Cardiovascular
Diseases During the COVID-19 Epidemic. Circulation 2020;141:e810-6.
5. Gao R. CIT 2018: A New Era, New Journey: Report from the China
Interventional Therapeutics (CIT) 2018, the largest interventional
cardiology scientific congress in the Asia-Pacific region. Eur Heart J
2018;39:2515-7.
6. Hohenschurz-Schmidt D, Vase L, Scott W, et al. Recommendations for
the development, implementation, and reporting of control interventions
in efficacy and mechanistic trials of physical, psychological, and
self-management therapies: the CoPPS Statement. BMJ 2023;381:e072108.
7. Gheorghiade M, Larson CJ, Shah SJ, et al. Developing New Treatments
for Heart Failure: Focus on the Heart. Circ Heart Fail 2016;9:e002727.
8. Cottler LB, Nagarajan R. Real-time assessment of community health
needs and concerns. Sci Transl Med 2012;4:119mr2.
9. Anderson JE, Aase K, Bal R, et al. Multilevel influences on resilient
healthcare in six countries: an international comparative study
protocol. BMJ Open 2020;10:e039158.
10. Holmes C, McDonald F, Jones M, Graham J. Knowledge Translation:
Moving Proteomics Science to Innovation in Society. OMICS
2016;20:352-61.
11. Ortmann O, Torode J, Harrison C, Bruns J, Helbig U; Participants of
the ERTM. Research driving innovation: what are key factors for
successful integration of translational science into oncology care
concepts? 5th European Roundtable Meeting (ERTM) May 4th, 2018, Berlin,
Germany. J Cancer Res Clin Oncol 2019;145:1521-5.
12. Khan SS, Post WS, Guo X, et al. Coronary Artery Calcium Score and
Polygenic Risk Score for the Prediction of Coronary Heart Disease
Events. JAMA 2023;329:1768-77.
13. Stähli BE, Varbella F, Linke A, et al. MULTISTARS AMI Investigators.
Timing of Complete Revascularization with Multivessel PCI for Myocardial
Infarction. N Engl J Med 2023;389:1368-79.
14. Writing Committee for the REMAP-CAP Investigators; Lawler PR, Derde
LPG, van de Veerdonk FL, et al. Effect of Angiotensin-Converting Enzyme
Inhibitor and Angiotensin Receptor Blocker Initiation on Organ
Support-Free Days in Patients Hospitalized With COVID-19: A Randomized
Clinical Trial. JAMA 2023;329:1183-96.
15. McCarthy MW, Naggie S, Boulware DR, et al. Accelerating COVID-19
Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group and
Investigators. Effect of Fluvoxamine vs Placebo on Time to Sustained
Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized
Clinical Trial. JAMA 2023;329:296-305.
16. Cao Z, Gao W, Bao H, et al. VV116 versus Nirmatrelvir-Ritonavir for
Oral Treatment of Covid-19. N Engl J Med 2023;388:406-17.
17. Sandhu HK, Booth K, Furlan AD, et al. Reducing Opioid Use for
Chronic Pain With a Group-Based Intervention: A Randomized Clinical
Trial. JAMA 2023;329:1745-56.
18. Ladapo JA, Orstad SL, Wali S, et al. Effectiveness of Goal-Directed
and Outcome-Based Financial Incentives for Weight Loss in Primary Care
Patients With Obesity Living in Socioeconomically Disadvantaged
Neighborhoods: A Randomized Clinical Trial. JAMA Intern Med
2023;183:61-9.
19. Simbiri KO, Williams CK, Macaluso M, Giordano A. Promoting Cancer
Control in Africa With ”Ubuntu”: A Report of the African Organization
for Research and Training in Africa (AORTIC) 10th Conference, 2015 in
Marrakech, Morocco. J Cell Physiol 2017;232:2287-95.
20. Hu C. A new “single” era of biomedicine and implications in
disease research. J Bio-X Res 2023;6:37-48.
21. Schnabel RB, Marinelli EA, Arbelo E, et al. Early diagnosis and
better rhythm management to improve outcomes in patients with atrial
fibrillation: the 8th AFNET/EHRA consensus conference. Europace
2023;25:6-27.
22. Baldassarre D, Iacoviello L, Baetta R, et al. CV-PREVITAL Study
Group. Rationale and design of the CV-PREVITAL study: an Italian
multiple cohort randomised controlled trial
investigating innovative digital strategies in primary cardiovascular
prevention. BMJ Open 2023;13:e072040.
23. Yu Z, Fidler TP, Ruan Y, et al. Genetic modification of
inflammation- and clonal hematopoiesis-associated cardiovascular risk. J
Clin Invest 2023;133:e168597.
24. Gray MP, Berman Y, Bottà G, et al. PPP-CAD Collaborators.
Incorporating a polygenic risk score-triaged coronary calcium score into
cardiovascular disease examinations to identify subclinical coronary
artery disease (ESCALATE): Protocol for a prospective, nonrandomized
implementation trial. Am Heart J 2023;264:163-73.
25. Matsushita K, Kaptoge S, Hageman SHJ, et al. Including measures of
chronic kidney disease to improve cardiovascular risk prediction by
SCORE2 and SCORE2-OP. Eur J Prev Cardiol 2023;30:8-16.
26. Mark PB, Carrero JJ, Matsushita K, et al. Major cardiovascular
events and subsequent risk of kidney failure with replacement therapy: a
CKD Prognosis Consortium study. Eur Heart J 2023;44:1157-66.
27. Huang Y, Cheung CY, Li D, et al. AI-integrated ocular imaging for
predicting cardiovascular disease: advancements and future outlook. Eye
(Lond) 2023; Sep 14. doi: 10.1038/s41433-023-02724-4.
28. Yan Z, Zhong L, Zhu W, Chung SK, Hou P. Chinese herbal medicine for
the treatment of cardiovascular diseases ─ Targeting cardiac ion
channels. Pharmacol Res 2023;192:106765.
29. Li C, Wang C, Hao J, et al. Level of evidence supporting the Chinese
cardiovascular disease clinical practice guidelines and its evolution in
the past two decades. Lancet Reg Health West Pac 2023;36:100773.
30. Hu C. Emergency Protective Measures and Strategies of Covid-19: From
Lifestyle to Traditional Chinese Medicine. Clin Complement Med Pharmacol
2023;3:100089.